Why the study?
Do AT1 receptor antagonists provide equal antihypertensive efficacy and better safety compared to ACE inhibitors in patients with essential hypertension?
Population
Patients with high blood pressure (essential hypertension)
Comparison
Angiotensin II type 1 (AT1) receptor antagonists vs Angiotensin converting enzyme (ACE) inhibitors
Design
Review
Authors
Loading...
Supports AT1 receptor antagonists for better tolerability in hypertension; leaves open whether pharmacokinetic differences affect clinical outcomes.
Do AT1 receptor antagonists provide equal antihypertensive efficacy and better safety compared to ACE inhibitors in patients with essential hypertension?
AT1 receptor antagonists offer a qualitative improvement in hypertension treatment due to comparable efficacy to ACE inhibitors and a better safety profile.
Kirch et al. (2001) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: